Prognostic relevance of KRAS and BRAF mutations in Japanese patients with colorectal cancer.
about
Association between clinicopathological features and survival in patients with primary and paired metastatic colorectal cancer and KRAS mutation.A very low incidence of BRAF mutations in Middle Eastern colorectal carcinoma.Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer.Prognostic value of KRAS and BRAF mutations in curatively resected colorectal cancerPrevalence of KRAS, BRAF, PI3K and EGFR mutations among Asian patients with metastatic colorectal cancerAnalysis of colorectal cancers in British Bangladeshi identifies early onset, frequent mucinous histotype and a high prevalence of RBFOX1 deletion.Mutation profiling in chinese patients with metastatic colorectal cancer and its correlation with clinicopathological features and anti-EGFR treatment response.Sex differences in the prognostic significance of KRAS codons 12 and 13, and BRAF mutations in colorectal cancer: a cohort study.Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern.Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer.BRAF mutation is associated with distinct clinicopathological characteristics in colorectal cancer: a systematic review and meta-analysis.Prognostic value of KRAS codon 13 gene mutation for overall survival in colorectal cancer: Direct and indirect comparison meta-analysis.Prognostic value of BRAF V600E mutation and microsatellite instability in Japanese patients with sporadic colorectal cancer.The pattern of KRAS mutations in metastatic colorectal cancer: a retrospective audit from Sri Lanka.Clinicopathologic Significance of BRAF Mutation and Extracellular Signal Regulated Kinase 1/2 Expression in Patients With a Colorectal AdenocarcinomaImmunohistochemical detection of the BRAF V600E mutant protein in colorectal cancers in Taiwan is highly concordant with the molecular test.Mutations of key driver genes in colorectal cancer progression and metastasis.Distinct molecular features of colorectal cancer in Ghana.The Expression of CCAT2, a Novel Long Noncoding RNA Transcript, and rs6983267 Single-Nucleotide Polymorphism Genotypes in Colorectal Cancers.Elucidating the prognostic significance of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese patients with metastatic colorectal cancer.Molecular spectrum of KRAS, BRAF, and PIK3CA gene mutation: determination of frequency, distribution pattern in Indian colorectal carcinoma.Development of ultra-short PCR assay to reveal BRAF V600 mutation status in Thai colorectal cancer tissues.Clinical Validation of Newly Developed Multiplex Kit Using Luminex xMAP Technology for Detecting Simultaneous RAS and BRAF Mutations in Colorectal Cancer: Results of the RASKET-B Study
P2860
Q33739940-D4662B52-7017-4F46-ABF5-36D31F6908F6Q33945376-94D782EE-F65D-4FA4-AF60-D6762196A3D1Q35001203-97775510-60D5-40F0-83C1-A81FB4A4CB8EQ35012132-3C086442-9E38-4B36-9490-D1BDC8E42D1DQ36085837-903E1083-EBA9-4290-A4E0-3A359C43D904Q36531671-1EA7F47D-4682-4C3A-A66A-C7456086C773Q37317549-4EAFB975-666E-4503-97E0-1ED0CD33BABBQ37355802-F73AA8DA-6679-4B1E-855A-35326CAEF60CQ37525272-284677CF-0AD7-4642-A6FB-FC23F36ED394Q37708015-AC9B9CA5-86CF-468B-A961-13ABD9790BA5Q38151250-7ED44B3A-D305-488A-A33A-0D3B863EE087Q38600228-EEC8A853-21E1-4E78-ADE6-99B9C73CC29CQ40564690-DDA0691E-A23E-4E1E-BE38-8C00FD816A68Q41361628-B5402CC7-F3B3-470D-9AA9-A88F309880D9Q41875891-2F67699F-5607-406A-82ED-F1862F905DD8Q48070124-6CA45C9F-9526-49E9-984B-E13F4A6C4B03Q50097873-6D1F65C2-5D97-4604-87BE-F598C8CBC0ABQ50781061-257A8101-DD9C-407D-925D-51D4FC4A0464Q51051659-387BC970-2B1C-4CEE-963F-E3D5DDF8E9CFQ53548338-2ED2542A-A383-4558-B8B0-3FDAA2230CFAQ54334205-F299CA35-2C15-4771-BAE9-9419A471FCDCQ54976792-DCA8EE4F-76C6-4F23-9335-83E39E632816Q58608206-9AD18E6A-1B9A-4B2C-B9B6-9D92395F7471
P2860
Prognostic relevance of KRAS and BRAF mutations in Japanese patients with colorectal cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Prognostic relevance of KRAS a ...... tients with colorectal cancer.
@en
Prognostic relevance of KRAS a ...... tients with colorectal cancer.
@nl
type
label
Prognostic relevance of KRAS a ...... tients with colorectal cancer.
@en
Prognostic relevance of KRAS a ...... tients with colorectal cancer.
@nl
prefLabel
Prognostic relevance of KRAS a ...... tients with colorectal cancer.
@en
Prognostic relevance of KRAS a ...... tients with colorectal cancer.
@nl
P2093
P2860
P1476
Prognostic relevance of KRAS a ...... tients with colorectal cancer.
@en
P2093
Hiroshi Saeki
Hiroyuki Kitao
Jun Harada
Munkhbold Tuul
Ryota Nakanishi
Takefumi Ohga
Yoshihiro Kakeji
P2860
P2888
P304
P356
10.1007/S10147-012-0501-X
P577
2012-11-29T00:00:00Z
P6179
1015190056